News of the WeekPatents

Company Gets Rights to Cloned Human Embryos

Science  28 Jan 2000:
Vol. 287, Issue 5453, pp. 559
DOI: 10.1126/science.287.5453.559

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

A U.S. company has received two British patents that appear to grant it commercial rights to human embryos created by cloning. The precedent-setting patents, issued last week on the cloning method that produced Dolly the sheep, have sparked protests from groups concerned about the ethics of biotechnology patents, especially those covering human genes or cells.

Related Content